Angel L. Troche-Torres

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer

Luis D. Borrero-García, Nilmary Grafals-Ruiz, S. Dharmawardhane, 2020, BMC cancer.